News

Billed as “ending crime and disorder on America’s streets,” the order would shift funds away from “housing first” and “harm ...
Using opioid settlement funds, the Opioid Advisory Committee and Recovery is Happening have established one of Minnesota's only vending machines dedicated to naloxone distribution. Stocked with the ...
NARCAN® Nasal Spray is the first FDA-approved, over-the-counter (OTC) 4 mg naloxone product for the emergency treatment of opioid overdose.
Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measures One-year mark of Ready to Rescue public awareness campaign to expand ...
Emergent BioSolutions Inc. has announced a three-year agreement valued at approximately $65 million to supply NARCAN® Nasal Spray to the Ontario Ministry of Health for the Ontario Naloxone Program.
Alongside over-the-counter NARCAN ® Nasal Spray 4 mg, prescription KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to distribute multiple life-saving opioid overdose ...
A Baton Rouge man was revived and charged with hit-and-run after overdosing while his wife and kid were in a vehicle, ...
Customer-focused approach and continued investments in NARCAN® Nasal Spray supply-readiness efforts help ensure opioid emergency preparednessGAITH ...
Nashville's night mayor leads initiative to place Narcan boxes in all public schools, bringing opioid overdose prevention to ...
It’s not every day we use Narcan on a four-legged patient—but our teams are ready for just about anything,” the department ...
GAITHERSBURG, Md., March 13, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) is strengthening relationships with partners across sectors and continuing its commitment to ensuring ...